APA 6th Edition Grce, M., Matovina, M., Milutin-Gašperov, N. i Sabol, I. (2010). Advances in Cervical Cancer Control and Future Perspectives. Collegium antropologicum, 34 (2), 731-736. Preuzeto s https://hrcak.srce.hr/56546
MLA 8th Edition Grce, Magdalena, et al. "Advances in Cervical Cancer Control and Future Perspectives." Collegium antropologicum, vol. 34, br. 2, 2010, str. 731-736. https://hrcak.srce.hr/56546. Citirano 21.01.2020.
Chicago 17th Edition Grce, Magdalena, Mihaela Matovina, Nina Milutin-Gašperov i Ivan Sabol. "Advances in Cervical Cancer Control and Future Perspectives." Collegium antropologicum 34, br. 2 (2010): 731-736. https://hrcak.srce.hr/56546
Harvard Grce, M., et al. (2010). 'Advances in Cervical Cancer Control and Future Perspectives', Collegium antropologicum, 34(2), str. 731-736. Preuzeto s: https://hrcak.srce.hr/56546 (Datum pristupa: 21.01.2020.)
Vancouver Grce M, Matovina M, Milutin-Gašperov N, Sabol I. Advances in Cervical Cancer Control and Future Perspectives. Collegium antropologicum [Internet]. 2010 [pristupljeno 21.01.2020.];34(2):731-736. Dostupno na: https://hrcak.srce.hr/56546
IEEE M. Grce, M. Matovina, N. Milutin-Gašperov i I. Sabol, "Advances in Cervical Cancer Control and Future Perspectives", Collegium antropologicum, vol.34, br. 2, str. 731-736, 2010. [Online]. Dostupno na: https://hrcak.srce.hr/56546. [Citirano: 21.01.2020.]
Sažetak The knowledge that the persistent infection with high-risk (HR) human papillomavirus (HPV) is the etiological factor in the development of cervical cancer has led to the development of the HPV DNA detection methods as well as the prophylactic vaccine against the most common HR-HPV types, HPV 16 and 18. Despite HPV vaccination, cervical cancer screening will remain the main preventive measure for both vaccinated and non-vaccinated women, but the nature of screening and management of women with cervical disease is being adapted to the new technologies. Although, HPV DNA detection is more sensitive that cytology, its specificity is lower, since most HPV infections are transient. Therefore, other methods are considered to improve the management of women with cervical disease. Typing of HPV DNA and viral load measurements are still used for research purposes only. Detection of viral oncogene E6/E7 transcripts, which is the marker of the productive infection, is a promising tool for follow-up of HPV DNA-positive women. The detection of p16INK4a over-expression, as an indirect test of E6/E7 expression, is used for confirmation of cervical neoplasia. Despite the lack of standardization, the detection of p16INK4a is useful in clinical settings, however its reproducibility in the management of low-grade and borderline cases is low. Future perspectives include the determination of the methylation status of several cellular genes that could predict the progression of the disease.